Cancer News

November Is National Lung Cancer Awareness Month (10/23/2018)

Treatment advances – lung cancer resources and advocacy are making the difference The month of November brings lung cancer into focus. Over the past few years great strides have been made in the treatment of non-small cell lung cancer due to the advancement of precision cancer medicines and immunotherapy. Lung cancer however remains the second …

Continue reading "November Is National Lung Cancer Awareness Month"

Opdivo® (nivolumab) Approved for Treatment of Small Cell Lung Cancer (08/23/2018)

The U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) for the treatment of metastatic small cell lung cancer (SCLC) whose cancer has progressed after platinum-based chemotherapy and at least one other line of therapy.1 About Small Cell Lung Cancer According to the American Cancer Society, more than 234,000 people will be diagnosed with …

Continue reading "Opdivo® (nivolumab) Approved for Treatment of Small Cell Lung Cancer"

Precision Cancer Medicine PARP Inhibitor Promising Treatment for Small Cell Lung Cancer (06/25/2018)

The results of a recent study published in The Journal of Clinical Oncology suggest the first new therapeutic option for Small Cell Lung Cancer (SCLC) in many years.  The study evaluated the addition of a novel precision cancer medicine called a PARP inhibitor to standard chemotherapy improved overall response rates and delayed cancer progression in patients …

Continue reading "Precision Cancer Medicine PARP Inhibitor Promising Treatment for Small Cell Lung Cancer"

Keytruda® Active in Small Cell Lung Cancer (12/27/2016)

Recently updated findings from the phase 1b KEYNOTE-028 study investigating the use of Keytruda® (pembrolizumab) in small cell lung cancer (SCLC) were recently presented at the 17th World Conference on Lung Cancer. Lung cancer remains the leading cause of cancer-related deaths worldwide. In the United States, SCLC accounts for 10-20% of all lung cancers. Although progress … Continue reading "Keytruda® Active in Small Cell Lung Cancer"

Personalized Lung Cancer Care & Precision Medicine (11/08/2016)

Targeted and more-individualized treatment for NSCLC becomes a reality. Lung cancers used to be diagnosed solely by a visual microscopic examination of tumor tissue and all patients received the same chemotherapy. Now, doctors are personalizing care by finding the genetic alterations within the cancer that drive its growth and then use medicines that specifically counteract … Continue reading "Personalized Lung Cancer Care & Precision Medicine"

Two-Drug Immunotherapy Deemed Safe for Small Cell Lung Cancer Patients, Moffitt Study Shows (06/06/2016)

Small cell lung cancer (SCLC) represents approximately 14 percent of all types of lung cancer. Many patients with SCLC respond to initial chemotherapy; however, they eventually relapse and develop progressive disease that has no effective treatment options. A new Moffitt Cancer study being presented at the ASCO Annual Meeting in Chicago and published in The … Continue reading "Two-Drug Immunotherapy Deemed Safe for Small Cell Lung Cancer Patients, Moffitt Study Shows"